Gilboa Therapeutics
Gilboa Therapeutics a next-generation cancer immunotherapy company focused on the development of novel and transformative cell therapies designed to harness the power of a patient's own immune system to more effective treat a wide range of cancer types, with a mission to dramatically improve patient outcomes and save lives.
Industries
biotechnology
Nr. of Employees
small (1-50)
Products
SolidT Cell Therapy
A genetically engineered autologous T cell therapy designed to target and kill solid tumor cells using tumor-specific antibodies as intermediaries.
SolidT Cell Therapy
A genetically engineered autologous T cell therapy designed to target and kill solid tumor cells using tumor-specific antibodies as intermediaries.